| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2955 |
| Trial ID | NCT05269914 |
| Disease | Diffuse Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | XKDCT023 |
| Recruitment status | Not Recruiting |
| Title | Safety, Efficacy and Pharmacokinetics of XKDCT023 in DLBCL |
| Year | 2022 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Qingdao University |
| Other ID(s) | XKDCT023-DLBCL |
| Cohort 1 | |||||||||||
|
|||||||||||